Lanean...
2-Oxoamide inhibitors of cytosolic group IVA phospholipase A(2) with reduced lipophilicity
Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity...
Gorde:
| Argitaratua izan da: | Bioorg Med Chem |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014611/ https://ncbi.nlm.nih.gov/pubmed/27522578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.07.057 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|